Article Details
Retrieved on: 2018-04-10 13:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Enanta Pharmaceuticals logo <b>Two Sigma Investments</b> LP boosted its position in Enanta Pharmaceuticals (NASDAQ:ENTA) by 322.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 58,955 shares of the biotechnology company's stock after purchasing ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here